INTERFERON-ALPHA ANTIBODIES IN PATIENTS WITH RENAL-CELL CARCINOMA TREATED WITH RECOMBINANT INTERFERON-ALPHA-2A IN AN ADJUVANT MULTICENTER TRIAL

Erstveröffentlichung
1993Authors
Prummer, O
Alefelder, J
Bertels, C
Graff, J
Haupt, G
Wissenschaftlicher Artikel
Published in
Cancer ; 71 (1993), 5. - S. 1828-1834. - ISSN 0008-543X
Link to publication
https://dx.doi.org/10.1002/1097-0142(19930301)71:5<1828::AID-CNCR2820710518>3.0.CO;2-0Institutions
UKU. Klinik für Innere Medizin IIISubject headings
[Free subject headings]: INTERFERON-ALPHA | INTERFERON ANTIBODIES | INTERFERON INHIBITORS | BETA-2-MICROGLOBULIN | RENAL CELL CARCINOMA | TREATMENT | antitumor-activity | neutralizing antibodies | clinical-significance | leukemia | therapy | alfa-2a | serum[DDC subject group]: DDC 610 / Medicine & health